Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma

By: News Direct

March 09, 2023 at 07:53 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human volunteer LPS challenge trial for lead molecule POLB 001.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/proactives-robin-davison-publishes-fresh-research-note-on-poolbeg-pharma-346100498

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

Intel Stock Hits All-Time Highs: Is the Turnaround Priced In? ↗

Today 10:35 EDT

Via MarketBeat

ServiceNow's 18% Drop: AI Fears Continue, But May Be Overblown ↗

Today 10:00 EDT

Via MarketBeat

Poll Reveals: Which Stores That No Longer Exist Do People Miss Most? [2026] ↗

Today 9:45 EDT

Via MarketBeat

STMicronelectronics Sends Industrial Chips Into Overdrive ↗

Today 9:25 EDT

Via MarketBeat

Sonoco Stock Drops as Inflation Hits Q1 Results ↗

Today 8:50 EDT

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	259.94	+4.85 (1.90%)
AAPL	272.09	-1.34 (-0.49%)
AMD	343.37	+38.04 (12.46%)
BAC	52.33	-0.14 (-0.27%)
GOOG	335.89	-1.86 (-0.55%)
META	666.34	+7.19 (1.09%)
MSFT	418.50	+2.75 (0.66%)
NVDA	206.75	+7.12 (3.56%)
ORCL	172.44	-3.84 (-2.18%)
TSLA	374.92	+1.20 (0.32%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.